Deep Health AI India Ltd revises FY26 audit report
Deep Health AI India Ltd submitted a revised audit report for FY26 to include entity names in the consolidated financial statements, confirming no change in financial results. The auditor flagged key matters regarding an exceptional loss on a proposed acquisition and the deviation in utilization of Rights Issue proceeds.

*this image is generated using AI for illustrative purposes only.
Deep Health AI India Ltd submitted a revised audit report for the financial year ended March 31, 2026, to the BSE. The revision incorporates the names of entities covered under the Consolidated Financial Statements, which were inadvertently omitted in the previous filing. The company clarified that there is no change in the audited standalone and consolidated financial results as a result of this update.
The Board of Directors had approved the audited standalone and consolidated financial results at its meeting held on May 29, 2026. The subsequent observation regarding the omission of entity names in the Auditor's Report prompted the filing of the revised document. The company stated that the omission was purely inadvertent and does not impact the financial results or the audit opinion.
The independent auditor, VRSK & Co. LLP, highlighted two key audit matters in the report. The first concerned accounting implications arising from a proposed acquisition of Oasis Ceramics Pvt. Ltd. under the Insolvency and Bankruptcy Code, 2016. The company recognised an exceptional loss related to the amount paid and a bank guarantee of ₹3.21 crore that was invoked due to delays in payment timelines.
The second key audit matter addressed the utilization of proceeds from a Rights Issue. The company raised ₹39.97 crore during the year but utilised only ₹2.5 crore towards the objects stated in the Letter of Offer. The balance amount of ₹37.47 crore was utilised for other purposes, primarily investment in securities, a deviation that was ratified by shareholders on January 22, 2026.
Utilization of Rights Issue Proceeds
| Nature of Securities | Purpose for which funds were raised | Total Amount raised | Amount utilized for the other purpose | Unutilized balance as at the Balance sheet date | Remarks |
|---|---|---|---|---|---|
| Equity Shares | Acquisition of Oasis Ceramics Private Limited | 30,00,000 | 30,00,000 | 0 | Entire amount diverted to investment in Equity. |
| Equity Shares | To meet General corporate purposes | 9,62,760 | 7,61,260 | 0 | Partially utilised; balance diverted to investment in Equity and share issue expense. |
| Equity Shares | To meet the expenses of the Issue | 35,000 | 0 | 0 | Excess Utilization Rs 13.86 Lacs |
The auditor affirmed that the internal financial controls over financial reporting were adequate and operating effectively as of March 31, 2026. The revised report was signed by Suresh G. Kothari, Partner at VRSK & Co. LLP, on May 29, 2026.
Historical Stock Returns for Deep Health AI
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.96% | -3.38% | -14.89% | -62.34% | -51.92% | +81.82% |
What is the expected timeline for the completion of the Oasis Ceramics acquisition under the Insolvency and Bankruptcy Code?
How will the significant deviation in Rights Issue proceeds utilization impact the company's ability to raise future capital?
What specific securities did the company invest the diverted ₹37.47 crore in, and what is the current valuation of those investments?































